140
Participants
Start Date
November 12, 2020
Primary Completion Date
September 6, 2022
Study Completion Date
January 15, 2023
Anticoagulation Agents (Edoxaban and/or high dose LMWH)
In-hospital (ICU \& normal ward): weight-adapted LMWH, high dose/ therapeutic dose (according to respective SmPC) After discharge and in ambulatory patients: Edoxaban according to SmPC until
Low dose Low molecular weight heparin or Placebo
In-hospital (ICU \& normal ward): LMWH, prophylactic dose as part of SOC After discharge and in ambulatory patients: Administration of oral pla-cebo according to the dosing rules for Edoxaban
UK Aachen, Aachen
Universitätsklinikum Augsburg, Augsburg
Universitätsklinikum Düsseldorf, Düsseldorf
Universitätsklinikum Freiburg, Freiburg im Breisgau
Asklepios Klinik Altona, Hamburg
Asklepios Klinik Barmbek, Hamburg
Asklepios Klinik St. Georg, Hamburg
Universitärsklinikum Hamburg-Eppendorf, Hamburg
Medizinische Hochschule Hannover, Hanover
TU München Klinikum rechts der Isar, München
Universitätsklinikum Hamburg-Eppendorf
OTHER